| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 141 | 면역보강제 | KR1020137012598 | 2011-10-14 | KR101806435B1 | 2017-12-07 | 에스케센도르테 |
| 본발명은 L. 카세이 431 또는 BB-12와같은프로바이오틱박테리아를인플루엔자백신과공투여 (co-administering)함으로써백신의효능을증강시키는방법에관한것이다. 또한, 본발명은그러한치료에사용하기위한조성물에관한것이다. | ||||||
| 142 | 비피도박테리움 아니말리스 아종 아니말리스 균주 | KR1020157017301 | 2013-12-10 | KR1020150095717A | 2015-08-21 | 르그래인-라스파우드,소피; 그롬폰,지안프란코; 카프로니어,산드린; 스모크비나,타마라; 데지브리,마리-크리스틴; 레식,빌리아나; 네운리스트,미셸 |
| 본 발명은 특히 장 신경계(enteric nervous system)의 기능을 향상시킬 수 있는 신규한 균주인 비피도박테리움 아니말리스 아종 아니말리스( Bifidobacterium animalis ssp. animalis ) 및 상기 신규한 균주를 포함하는 조성물에 관한 것이다. | ||||||
| 143 | 면역보강제 | KR1020137012598 | 2011-10-14 | KR1020130124948A | 2013-11-15 | 에스케센도르테 |
| 본 발명은 L. 카세이 431 또는 BB-12와 같은 프로바이오틱 박테리아를 인플루엔자 백신과 공투여 (co-administering)함으로써 백신의 효능을 증강시키는 방법에 관한 것이다. 또한, 본 발명은 그러한 치료에 사용하기 위한 조성물에 관한 것이다.
|
||||||
| 144 | 비피도박테리움 박테리아에 의한 복부 둘레의 감소 방법 | KR1020107016395 | 2008-12-19 | KR1020100102178A | 2010-09-20 | 구필푀유라나탈리; 귀요네드니; 쟈콥슈테판 |
| 본 발명은 생균제, 바람직하게
Bifidobacterium 속의 박테리아를 투여함으로써 대상에서 복부 둘레를 감소시키는 방법에 관한 것으로, 상기 방법은 본 발명의 한 측면으로는 비-치료적인 방법이고, 본 발명의 또 다른 측면으로 IBS(irritable bowel syndrome, 과민성 대장 증후군)를 치료하는 방법이다.
|
||||||
| 145 | COMPOSITION FOR REDUCING INTESTINAL GAS PRODUCTION | EP15720121 | 2015-04-23 | EP3285785A1 | 2018-02-28 | LE NEVE BORIS; ROCHER EMILIE; GUYONNET DENIS |
| The present invention relates to a composition comprising Bifidobacterium bacteria for use for reducing intestinal gas production in an individual. | ||||||
| 146 | Method for stimulating intestinal barrier integrity after non-natural birth | EP11178047.4 | 2006-10-06 | EP2407036B1 | 2015-11-04 | Schmitt, Joachim; Boehm, Günther; Beermann, Christopher |
| The present invention relates to methods for feeding and to compositions to be adminis | ||||||
| 147 | USE OF BIFIDOBACTERIUM ANIMALIS FOR TREATING OR PREVENTING BODY WEIGHT GAIN AND INSULIN RESISTANCE | EP12890225.1 | 2012-12-20 | EP2935560A1 | 2015-10-28 | SHEN, Jian; WANG, JingJing; ZHAO, Liping; OBIN, Martin Saul; DERRIEN, Muriel; ROCHER, Emilie; HYLCKAMA VLIEG, Johan Van |
| Provided is the use of Bifidobacterium animalis subsp. lactis strain CNCM I-2494 for decreasing diet-induced body weight gain and improving diet-induced insulin resistance in a subject. | ||||||
| 148 | BIFIDOBACTERIA THAT PRODUCES FOLIC ACID, FOOD COMPOSITION AND USE OF SAID BIFIDOBACTERIA | EP09750794.1 | 2009-05-21 | EP2305838B1 | 2015-01-28 | GARZA GONZÁLEZ, Elvira; BOSQUES PADILLA, Francisco Javier; NARANJO MODAD, Sandra; MORENO CAMPAÑA, Víctor Manuel |
| A bacterial strain of human origin belonging to the species Bifidobacterium animalis identified as PTA-9175 which produces between 120 ng/ml to 398 ng/ml of folic acid and which can be used as a probiotic in food compositions. The Bifidobacterium animalis strain is deposited with the American Type Culture Collection (ATCC) in the United States of America, under the Budapest Treaty, dated on April 23, 2008, and respectively identified with the ATCC deposit designation number for patent as PTA-9175. | ||||||
| 149 | PROBIOTIC FOR ADMINISTRATION TO HEALTHY YOUNG MAMMALS DURING THE WEANING PERIOD FOR IMPROVING TOLERANCE TO NEWLY INTRODUCED FOOD STUFFS | EP12751274.7 | 2012-07-11 | EP2731458A1 | 2014-05-21 | DUNCKER, Swantje; LEWIS, Marie; MERCENIER, Annick; SINGH, Anurag; BAILEY, Michael |
| The current invention is based upon administration of a probiotic, B. Lactis NCC2818 to healthy young mammals during the critical weaning period (in infants this period is usually from about 3 months to about 12, 18 or 24 months old), so as to accelerate the young mammal's adaptation to new food. The effectiveness of the invention is evidenced herein by morphological and immunological changes observed in a piglet animal model of weaning. Thus, administration of the probiotic according to the invention had a prophylactic effect, preventing the severe discomfort and pathological states associated with the introduction to novel foods during the weaning period. | ||||||
| 150 | Drying lactic acid bacteria and new compositions | EP14153377.8 | 2012-06-30 | EP2730646A1 | 2014-05-14 | Yde, Birgitte |
The invention relates to a dry composition comprising from 109 to 1013 cfu/g of the composition of lactic acid bacteria cells, wherein the composition is characterized by that it also comprises following amounts of protective agents (all amounts of protective agents below are given relative to 1 g of lactic acid bacteria cells in the composition): The composition provides an improved storage stability of the cell of interest, by way of the specific ratio between the amount of cells and protective agents.
|
||||||
| 151 | Method for stimulating intestinal barrier integrity after birth by caesarean section | EP09161674.8 | 2006-10-06 | EP2105055B1 | 2014-01-22 | Schmitt, Joachim; Boehm, Günther; Beermann, Christopher |
| The present invention relates to methods for feeding and to compositions to be adminis | ||||||
| 152 | BIFIDOBACTERIA THAT PRODUCES FOLIC ACID, FOOD COMPOSITION AND USE OF SAID BIFIDOBACTERIA | EP09750794 | 2009-05-21 | EP2305838A4 | 2014-01-08 | GARZA GONZALEZ ELVIRA; BOSQUES PADILLA FRANCISCO JAVIER; NARANJO MODAD SANDRA; MORENO CAMPANA VICTOR MANUEL |
| A bacterial strain of human origin belonging to the species Bifidobacterium animalis identified as PTA-9175 which produces between 120 ng/ml to 398 ng/ml of folic acid and which can be used as a probiotic in food compositions. The Bifidobacterium animalis strain is deposited with the American Type Culture Collection (ATCC) in the United States of America, under the Budapest Treaty, dated on April 23, 2008, and respectively identified with the ATCC deposit designation number for patent as PTA-9175. | ||||||
| 153 | Method for stimulating the intestinal flora | EP13171226.7 | 2006-10-20 | EP2638812A1 | 2013-09-18 | Boehm, Günther; Knol, Jan; Stahl, Bernd |
The present invention relates to methods for feeding and to compositions to be administered to infants delivered via caesarian section and in particular to the use of a) at least two different microorganisms; or b) at least one microorganism and at least one indigestible oligosaccharide; or c)at least two different Bifidobacteria species, subspecies or strains for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. Thereby it is possible to stimulate the healthy development of the intestinal flora of said infants. |
||||||
| 154 | IMMUNOADJUVANT | EP11768049.6 | 2011-10-14 | EP2627198A1 | 2013-08-21 | ESKESEN, Dorte |
| The invention thus relates to a method for boosting the efficiency of a vaccine by co-administering a probiotic bacterium such as L. casei 431 or BB-12 with an influenza vaccine. The invention further relates to a composition for use in such a treatment. | ||||||
| 155 | METHOD FOR IMPROVING THE SURVIVAL RATE OF PROBIOTIC | EP11748344.6 | 2011-08-16 | EP2605669A1 | 2013-06-26 | HENRIKSSON, Anders |
| The present invention relates to the improvement of the survival rate of probiotic strains such as Lactobacillus acidophilus or Bifidobacterium ssp. by Lactobacillus strains that enhance the survival rate of probiotic strains in food or feed products. | ||||||
| 156 | BIFIDOBACTERIA THAT PRODUCES FOLIC ACID, FOOD COMPOSITION AND USE OF SAID BIFIDOBACTERIA | EP09750794.1 | 2009-05-21 | EP2305838A2 | 2011-04-06 | GARZA GONZÁLEZ, Elvira; BOSQUES PADILLA, Francisco Javier; NARANJO MODAD, Sandra; MORENO CAMPAÑA, Víctor Manuel |
A bacterial strain of human origin belonging to the species Bifidobacterium animalis identified as PTA-9175 which produces between 120 ng/ml to 398 ng/ml of folic acid and which can be used as a probiotic in food compositions. The Bifidobacterium animalis strain is deposited with the American Type Culture Collection (ATCC) in the United States of America, under the Budapest Treaty, dated on April 23, 2008, and respectively identified with the ATCC deposit designation number for patent as PTA-9175. |
||||||
| 157 | Method for stimulating the intestinal flora in infants delivered by caesarean section | EP09011197.2 | 2006-10-20 | EP2140771A1 | 2010-01-06 | Boehm, Günther; Stahl, Bernd; Knol, Jan |
The present invention relates to methods for feeding and to compositions to be administered to infants delivered via caesarian section and in particular to the use of a) at least two different microorganisms; or b) at least one microorganism and at least one indigestible oligosaccharide; or c)at least two different Bifidobacteria species, subspecies or strains for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. Thereby it is possible to stimulate the healthy development of the intestinal flora of said infants. |
||||||
| 158 | METHOD FOR STIMULATING THE INTESTINAL FLORA | EP06806443.5 | 2006-10-20 | EP1940250B1 | 2009-09-16 | BOEHM, Günther; STAHL, Bernd; KNOL, Jan |
| The present invention relates to methods for feeding and to compositions to be adminis | ||||||
| 159 | HARTMETALL FÜR SCHNEIDPLATTEN VON KURBELWELLENFRÄSERN | EP06804351.2 | 2006-10-13 | EP1941069A1 | 2008-07-09 | GARCIA, José; KÖPF, Arno; KIPPERER, Karl; RUETZ-UDIER, Klaus |
| The invention relates to a hard metal comprising several hard material phases and a binder phase, a cutting element made of such a hard metal, and a crankshaft miller encompassing such a cutting element. In order to reduce the formation of undesired comb-type fractures in cutting plates, a hard metal is used for producing said cutting plates, more than 70 percent by weight of said hard metal being composed a hard material phase made of tungsten carbide having a mean grain size of less than 1.5µm while the hard metal contains at least 2.5 percent by weight of another hard material phase made of a tantalum carbide or a tantalum niobium carbide, a titanium carbide fraction amounting to less than 5.0 percent by weight. | ||||||
| 160 | PREVENTING DISEASES IN INFANTS DELIVERED VIA CAESAREAN SECTION | EP06799537.3 | 2006-10-06 | EP1940246A1 | 2008-07-09 | SCHMITT, Joachim; STAHL, Bernd; KNOL, Jan |
| The present invention relates to methods for feeding and to compositions to be adminis | ||||||
